AXIA Pharmaceutical Issues Recall for Injectable Drugs
AXIA Pharmaceutical has recalled many of its injectable drugs due to contamination.
Tuesday, January 21, 2020 - FUSION IV Pharmaceuticals, Inc., dba AXIA Pharmaceutical has issued a voluntary nationwide recall of a large number of injectable sterile drugs due to potential contamination. According to the company's statement, the recalled products are "inconsistent with federal guidelines."
Click here for a full list of recalled AXIA products.
According to the statement, the company has not received reports of adverse effects from the use of the recalled products. However, "Administration of a drug product intended to be sterile that is not sterile could result in serious infections which may be life-threatening."
The recall is posted on the FDA website here.
The recall is the second medical recall issued within a week due to sterility issues. Cardinal Health has issued a recall of many of its sterile gowns and surgery packs due to potential contamination which occurred at a Chinese manufacturing facility.
Consumers with questions about the recall should contact their healthcare provider.
If you have experienced an adverse reaction due to contamination of an AXIA injectable medication that has now been recalled, you may contact the FDA's MedWatch Adverse Event Reporting program by clicking here. It would also benefit you to contact a personal injury attorney.
Tags for This Article:
More Recent Lawsuit News:
- U.S. Residents Spend More than Twice as Much on Rx Drugs | 1/29/2021
- Soho Fresh Rubbing Alcohol Recalled for Methanol Contamination | 1/11/2021
- Penumbra Issues Urgent Recall of Stroke Catheter | 12/22/2020
- Zantac Makers Face DOJ Probe | 12/21/2020
- FDA Issues Warnings on Janumet and Januvia | 12/8/2020
No-Cost, No-Obligation Case Review.
OnderLaw, LLC in St. Louis has developed a solid reputation of excellence as a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation, including Pradaxa, Lexapro and Yasmin/Yaz, Actos, Risperdal and others. OnderLaw has won verdicts of more than $300 million in talcum powder ovarian cancer lawsuits and represent more Glyphosate victims than any other firm in the country.
